XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC
Clinical trial NCT03389659 · UNKNOWN
Trial details
- NCT number
- NCT03389659
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2021-12-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.